on TRANSGENE (EPA:TNG)
Transgene's General Meeting Approves Board Resolutions and New Appointments
On May 22, 2026, Transgene's Combined General Meeting took place at its headquarters in Illkirch-Graffenstaden, presided over by CEO Alessandro Riva. Shareholders approved all proposed resolutions, including those concerning financial reports and Director renewals.
The meeting confirmed the continuation of non-independent directors TSGH, represented by Sandrine Flory, and Benoît Habert. Independent directors Emmanuelle Quilès and Carol Stuckley also had their mandates renewed. Additionally, Dorothea Ledergerber and Solange Peters were appointed as new independent directors.
The updated board consists of 10 members, balancing independence and gender diversity with five independent directors and five women. Detailed voting results can be accessed on Transgene's website.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all TRANSGENE news